OKUR — OnKure Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1637715 ·
Last close
$2.58
Market Cap
$104.50M
52W High
$5.38
52W Low
$2.01
ADV30
393,459
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -19,351,000 | -17,846,000 | 167,077,000 | 151,443,000 | 9,340,000 |
| Jun 2026 | 0 | — | -16,899,000 | -15,346,000 | 179,353,000 | 166,502,000 | 7,245,000 |
| Mar 2026 | 0 | — | -15,615,000 | -15,157,000 | 198,694,000 | 192,106,000 | 14,341,000 |
| Dec 2025 | 0 | — | -14,125,000 | -13,503,000 | 62,117,000 | 59,050,000 | 5,933,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-47,886,000
Investing CF
$-11,853,000
Financing CF
$140,851,000
CapEx
$-49,000
Dividends Paid
—
Buybacks
$-8,000
EPS Diluted TTM
$-2.77
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-262,590,000
Inventory
—
Receivables
—
ST Investments
$11,862,000
EBIT TTM
$-63,857,000
Pretax Income TTM
$-61,852,000
Interest Exp TTM
$8,000
Analysts
4
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -62,950,000 | -59,517,000 | 62,117,000 | 5,933,000 | 56,184,000 | -51,828,000 |
| Dec 2024 | 0 | -54,386,000 | -52,673,000 | 114,907,000 | 11,079,000 | 103,828,000 | -51,117,000 |
| Dec 2023 | 0 | -36,934,000 | -35,311,000 | 35,734,000 | 137,576,000 | -101,842,000 | -34,546,000 |
| Dec 2022 | 0 | -29,766,000 | -29,512,000 | 15,999,000 | 70,417,000 | -54,418,000 | -26,953,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-58,705,000
OpCashFlow TTM
—
Assets (Latest)
$179,353,000
Forward EPS
$-1.53
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $2.82 · call volume: 10 · put volume: 1Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | $103.84M | $0.86 | — |
| ORGO | Organogenesis Holdings Inc. | $105.35M | $0.81 | — |
| NERV | Minerva Neurosciences, Inc. | $103.13M | $2.16 | — |
| NRXP | NRX Pharmaceuticals, Inc. | $106.07M | $2.45 | — |
| OGI | ORGANIGRAM GLOBAL INC. | $101.90M | $0.71 | — |
News headlines (Yahoo Finance, 1h cache)
OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
2026-11-04 21:05 · Yahoo
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
2026-08-31 12:00 · Yahoo
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
2026-08-04 20:05 · Yahoo
OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
2026-07-15 17:02 · Yahoo
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
2026-07-02 12:00 · Yahoo
OnKure Therapeutics Reports First Quarter 2026 Financial Results
2026-05-05 20:05 · Yahoo
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?
2026-04-16 13:18 · Yahoo
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
2026-03-27 12:00 · Yahoo
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-12 20:05 · Yahoo
Promising Penny Stocks To Watch In December 2025
2025-12-09 18:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.